top of page
  • Writer's picturePhilip Hockberger

Mansueto, Polsky back Northwestern biotech spinout

by John Pletz, Carin's Chicago Business, May 6, 2021

A Northwestern University drug-development spinout has raised $4 million from investors including Morningstar founder Joe Mansueto. Grove Biopharma uses artificial intelligence to create synthetic proteins, speeding up drug development and potentially making treatments safer and more effective. The company is commercializing technology developed by Northwestern researcher Nathan Gianneschi. Initially it will focus on Huntington’s and Parkinson’s diseases.

For more information, click here.

21 views0 comments

Recent Posts

See All

CBIA and WIB partner on Work-Life Integration Survey

CBIA and Women In Bio (WIB) have published results of a survey that addresses the needs of professional women working in the life sciences. "The concept of work–life integration reflects a growing des


bottom of page